Effect of COVID-19 Pandemic on Performance Measures in Acute Myocardial Infarction
https://doi.org/10.18087/cardio.2021.3.n1496
Abstract
Objective To assess performance measures of attention of STEMI in Coronary Intensive Care Unit in General Hospital Camilo Cienfuegos.
Methods Admitted patients with STEMI, from February-April 2020, were compared with patients from similar period from 2015–2019, and patients from January 2019 to January 2020. Primary endpoint were performance measures according to the 2017 AHA / ACC Clinical Performance and Quality Measures for Adults with STEMI document, and secondary endpoint were all-cause in-hospital mortality and major acute coronary events.
Results Only 35 patients were admitted from February-April 2020. When comparing with similar periods from recent years, in-hospital death (8.3 % vs. 20 %; p=0.03), major complications (38.7 % vs. 57.1 %; p=0.03), and cardiogenic shock (6.9 % vs. 17.4 %; p=0.04) were significantly higher. When comparing with 2019 and January 2020, in-hospital death (9.6 %; p=0.04), and major complications (35.8 % p=0.03) were significantly higher in February-April 2020; however, there was no difference in prevalence of cardiogenic shock (8 %; p=0.12).
Conclusion COVID-19 pandemic had decreased prevalence of STEMI, as well as some performance measures of attention in this center.
Supporting agencies: No conflict of interest is reported.
About the Author
Miguel Alejandro Rodriguez-Ramos
Universidad de Ciencias Medicas Sancti-Spiritus, Hospital General Camilo Cienfuegos, Cuba
Cuba
Cuba
General Cardiologist
References
1. Pilz S, Theiler-Schwetz V, Trummer C. Letter by Pilz et al Regarding Article, “Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment–Elevation Myocardial Infarction Care in Hong Kong, China”. Circulation: Cardiovascular Quality and Outcomes. 2020;13(5):e006734. DOI: 10.1161/CIRCOUTCOMES.120.006734
2. Rangé G, Hakim R, Motreff P. Where have the ST-segment elevation myocardial infarctions gone during COVID-19 lockdown? European Heart Journal - Quality of Care and Clinical Outcomes. 2020;6(3):223–4. DOI: 10.1093/ehjqcco/qcaa034
3. Kunal S, Gupta K, Sharma SM, Pathak V, Mittal S, Tarke C. Cardiovascular system and COVID-19: perspectives from a developing country. Monaldi Archives for Chest Disease. 2020;90(2). DOI: 10.4081/monaldi.2020.1305
4. Chieffo A, Stefanini GG, Price S, Barbato E, Tarantini G, Karam N et al. EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic. European Heart Journal. 2020;41(19):1839–51. DOI: 10.1093/eurheartj/ehaa381
5. Tanner R, MacDaragh Ryan P, Caplice NM. COVID-19 – Where Have All the STEMIs Gone? Canadian Journal of Cardiology. 2020;36(7): 1161.e9-1161.e10. DOI: 10.1016/j.cjca.2020.04.032
6. Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA et al. Reduction in ST-Segment Elevation Cardiac Catheterization Laboratory Activations in the United States During COVID-19 Pandemic. Journal of the American College of Cardiology. 2020;75(22):2871–2. DOI: 10.1016/j.jacc.2020.04.011
7. De Rosa S, Spaccarotella C, Basso C, Calabrò MP, Curcio A, Filardi PP et al. Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era. European Heart Journal. 2020;41(22):2083–8. DOI: 10.1093/eurheartj/ehaa409
8. Welt FGP, Shah PB, Aronow HD, Bortnick AE, Henry TD, Sherwood MW et al. Catheterization Laboratory Considerations During the Coronavirus (COVID-19) Pandemic. Journal of the American College of Cardiology. 2020;75(18):2372–5. DOI: 10.1016/j.jacc.2020.03.021
9. Ranard LS, Ahmad Y, Masoumi A, Chuich T, Romney M-LS, Gavin N et al. Clinical Pathway for Management of Suspected or Positive Novel Coronavirus-19 Patients With ST-Segment Elevation Myocardial Infarction. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine. 2020;19(2):49–54. DOI: 10.1097/HPC.0000000000000223
10. Sadeghipour P, Talasaz AH, Eslami V, Geraiely B, Vojdanparast M, Sedaghat M et al. Management of ST‐segment‐elevation myocardial infarction during the coronavirus disease 2019 (COVID‐ 19) outbreak: Iranian “247” National Committee’s position paper on primary percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. 2021;97(3): E346–51. DOI: 10.1002/ccd.28889
11. Chongprasertpon N, Coughlan JJ, Cahill C, Kiernan TJ. Circadian and seasonal variations in patients with acute STEMI: A retrospective, single PPCI center study. Chronobiology International. 2018;35(12):1663–9. DOI: 10.1080/07420528.2018.1500478
12. Jneid H, Addison D, Bhatt DL, Fonarow GC, Gokak S, Grady KL et al. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction. Journal of the American College of Cardiology. 2017;70(16):2048–90. DOI: 10.1016/j.jacc.2017.06.032
13. Tam C-CF, Cheung K-S, Lam S, Wong A, Yung A, Sze M et al. Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment– Elevation Myocardial Infarction Care in Hong Kong, China. Circulation: Cardiovascular Quality and Outcomes. 2020;13(4): e006631. DOI: 10.1161/CIRCOUTCOMES.120.006631
14. Yousefzai R, Bhimaraj A. Misdiagnosis in the COVID-19 Era: When Zebras are Everywhere, Don’t Forget the Horses. JACC: Case Reports. 2020;2(10):1614–9. DOI: 10.1016/j.jaccas.2020.04.018
15. Minhas AS, Scheel P, Garibaldi B, Liu G, Horton M, Jennings M et al. Takotsubo Syndrome in the Setting of COVID-19. JACC: Case Reports. 2020;2(9):1321–5. DOI: 10.1016/j.jaccas.2020.04.023
Review
For citations:
Rodriguez-Ramos M.A. Effect of COVID-19 Pandemic on Performance Measures in Acute Myocardial Infarction. Kardiologiia. 2021;61(3):52-56. https://doi.org/10.18087/cardio.2021.3.n1496
Views:
1115
Email this article 
Post a Comment 
